Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
81.20
-4.40 (-5.14%)
At close: Mar 27, 2026
-8.87% (1Y)
| Market Cap | 126.10B -11.9% |
| Revenue (ttm) | 38.04M -14.4% |
| Net Income | -351.92M |
| EPS | -0.23 |
| Shares Out | 1.55B |
| PE Ratio | n/a |
| Forward PE | 34.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,721,190 |
| Average Volume | 9,749,493 |
| Open | 85.00 |
| Previous Close | 85.60 |
| Day's Range | 79.70 - 85.30 |
| 52-Week Range | 54.10 - 277.00 |
| Beta | 0.46 |
| RSI | 17.18 |
| Earnings Date | May 5, 2026 |